Saudi Arabia | ISF hosts colorful Kannada Rajyotsava in Al-Khobar

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.

Mangaluru, Feb 8: Professional services company Cognizant on Friday opened a new facility in Mangaluru, expanding its presence in Karnataka. Located in the heart of the city, the new 100,000 sq- ft facility can accommodate more than 1,100 employees, the NASDAQ-listed company said in a statement.

Cognizant has had an association with Mangaluru since 2011 when it acquired CoreLogic Global Services Private Limited (CoreLogic India), the India-based captive operations of CoreLogic, one of the largest real estate information and analytics provider in the US market.

From its existing centre in Mangaluru, Cognizant provides consulting, enterprise applications and business process services in the area of mortgage processing covering property taxes, research and investigations, property data warehousing and management of geospatial data.

The company currently employs more than 600 professionals in Mangaluru, more than 50 per cent of whom are women.

In addition to experienced professionals, Cognizant also hires fresh graduates for its Mangaluru centre from leading institutions such as Sahyadari Institute of Technology and Management, Manipal Institute of Technology, N.M.A.M. Institute of Technology, St Joseph's College of Engineering, Canara Engineering College, N.I.T.K. Surathkal, PA College of Engineering and Srinivas College of Engineering, as mortgage origination and servicing specialists, business analysts, consultants, automation specialists and software engineers.

In Karnataka, Cognizant also has operations in Bengaluru and Mysuru. The company has more than 28,000 professionals in Bengaluru and nearly 700 professionals in Mysuru.

States and union territories of India, Service companies, Rail transport in Karnataka, Cognizant, Dun & Bradstreet, Teaneck, New Jersey,Transport in Karnataka, Transport in Mangalore, Mangalore, Karnataka, Udupi railway station, Mangalore Junction railway station, St Joseph's College of Engineering, Sahyadari Institute of Technology, CoreLogic Global Services Private Limited, Canara Engineering College, Srinivas College of Engineering,real estate information, PA College of Engineering, N.M.A.M. Institute of Technology, st joseph's, N.I.T.K. Surathkal, Manipal Institute of Technology, software engineers, United States, business process services, mortgage processing, Institute of Technology

Bengaluru, Mar 18: BJP MLC Lahar Singh Siroya on Wednesday wrote a letter to Karnataka Chief Minister B S Yeddyurappa, urging him to allow half-an-hour daily discussion in the State Assembly and Council to take stock and review preparation of the government to contain the spread of coronavirus.

"Since the entire world including India is facing an emergency-like situation, it is appropriate for lawmakers to discuss the matter in the legislature. I would like to request you to allow the matter to be discussed every day in the upper house," said Siroya in his letter to the Chief Minister.

He said discussion and suggestions on the issue can help the government to improve the surveillance activities.

He said members of the Assembly can bring realistic information from their districts and present the same before the House.

Stressing that Bengaluru is a global hub of software and electronic industries, Siroya said: "We need to step up surveillance on the improvement of the international community. So, we have to discuss in detail and devise a robust strategy to contain the spread of the disease."

He asserted there is a possibility of people using social media to mislead public.

"lf the government discusses and debates the issue besides making announcements if any, there will be no scope for social media to mislead the public. Media is doing a good job in educating people. So, I would like to request you to involve the media and select NGOs to sensitise people and bring in the preventive mechanism of self-quarantine more effectively," he said.

Two more people have tested positive for COVID-19 in Karnataka on Wednesday, taking the tally of infected persons in the state to 13, Health Minister B Sriramulu said.

A total of 147 positive cases of coronavirus have been reported in India so far, as per the Union Ministry of Health and Family Welfare. The deadly virus has claimed three lives in the country, the first one was reported from Karnataka.